Analysis

A significant update to U.S. cancer treatment protocols has substantially broadened the potential patient population for ImmunityBio's flagship immunotherapy. The...

The battle for technological supremacy in 2026 presents investors with a stark choice between two fundamentally different corporate philosophies. On...

Coeur Mining's financial strength and operational improvements have been formally recognized, with the company securing a "Strong Buy" rating from...

While The Trade Desk announces a significant new partnership with LinkedIn, its stock faces substantial headwinds. The pressure stems from...

In a bold financial maneuver, Salesforce has initiated the largest share repurchase program in its history, entirely funded through debt....

At this week's JPMorgan Industrials Conference, MP Materials CEO James Litinsky delivered an unusually pointed message to investors. He argued...

Precision Biosciences is progressing its gene therapy candidate for Duchenne muscular dystrophy (DMD), with investor attention now turning to a...

FMC Corporation finds itself navigating a complex and critical juncture. The company's leadership is actively engaged in discussions with as...

ZipRecruiter is making a bold move into generative artificial intelligence by integrating its job search platform directly within ChatGPT. This...

The biotechnology firm Codexis is transitioning its operations from a research-focused phase to establishing industrial production capabilities. Central to this...